GGrantIndex
Sort

50,496 grants matching lung cancer

Elucidating genetics of response to immune checkpoint blockade in lung cancer

$573,644
Naiyer A Rizvi · Columbia University Health Sciences · R01 · FY2017 · CA

In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)

$573,631
Andrei Goga · University Of California, San Francisco · R01 · FY2013 · CA

Activating Native Tumor Immunity with IL-33 Armored CARs

$573,520
Yina Hsing Huang · Dartmouth College · R01 · FY2023 · CA

Rapid and affordable magneto-nanosensors for ctDNA-guided lung cancer management

$573,461
Shan X. Wang · Stanford University · R01 · FY2021 · CA

A non-invasive gene-expression biomarker of airway response to tobacco exposure

$573,459
Avrum E Spira · Boston University Medical Campus · U01 · FY2009 · ES

Tools for Linking and Mining image and Genomic Data in Non-Small Cell Lung Cancer

$573,438
Sandy A Napel · Stanford University · R01 · FY2015 · CA

Penn Quantitative MRI Resource for Pancreatic Cancer

$573,399
Rong Zhou · University Of Pennsylvania · U24 · FY2018 · CA

Core B. Clinical & Biomarkers Core

$573,303
Dorothy K Hatsukami · University Of Minnesota · P01 · FY2022 · CA

Leveraging canine spontaneous cancer to optimize the power of blood biopsy

$573,297
Elinor Karlsson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA

Tumor-specific autoantibodies for SCLC early detection

$573,272
A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA

Development of 3D Alveolar Tissue Models, CRISPR-editing and Microbiota-immune Response Assay Platforms for Deciphering Human Lung Immunity

$573,207
Derya Unutmaz · Jackson Laboratory · U19 · FY2023 · AI

Neutrophil derived proteinases abolish the IFNG signature in NSCLC

$573,105
A. McGarry Houghton · Fred Hutchinson Cancer Center · R01 · FY2023 · CA

The Effect of Diet and Nutrients on the Progression and Treatment of Prostate Can

$573,098
George Thomas · University Of Cincinnati · U01 · FY2013 · CA

Therapeutic/Toxic Effects of Electron Emitting Nuclides

$573,076
Amin I Kassis · Harvard Medical School · R01 · FY2008 · CA

Molecular mechanisms of SCLC initiation and detection in mice and humans

$573,067
Mark A Krasnow · Stanford University · U01 · FY2019 · CA

Computer Support for the Colon Cancer Screening in PLCO Cancer Screening Trials

$573,034
William Lake · Information Management Services, Inc. · N02 · FY2011 · CA

Computational modeling of tumor burden by CT to advance cancer therapeutics

$573,026
Michael L. Maitland · Inova Health Care Services · R01 · FY2018 · CA

Nicotine and Chronic Kidney Disease

$573,010
Edgar A Jaimes · University Of Alabama At Birmingham · R01 · FY2010 · ES

Therapeutic strategies against EGFR exon 20 mutant lung cancer

$572,983
John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment

$572,907
Richard T Lee · Beckman Research Institute/City Of Hope · U01 · FY2024 · CA

Discovery and development of Ku-targeted small molecule inhibitors: A novel mechanism of DNA-PK inhibition

$572,781
John J Turchi · Indiana University Indianapolis · R01 · FY2022 · CA

Discovery and development of Ku-targeted small molecule inhibitors: A novel mechanism of DNA-PK inhibition

$572,781
John J Turchi · Indiana University Indianapolis · R01 · FY2023 · CA

Develop Conditionally Armored CAR Macrophage Therapy for Pancreatic Cancer

$572,707
Pingping Hou · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA

NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)

$572,671
Elaine R Mardis · Washington University · U01 · FY2012 · GM

EFFECT OF R1R2 OVER-EXPRESSION ON CARDIAC FUNCTION

$572,564
Michael Regnier · University Of Washington · R01 · FY2014 · HL